Flores, Bernardo A.
HRN: 22 70 65 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/29/2023
10/05/2023
IV
600mg
Q8
Acute Tonsillopharyngitis
Waiting Final Action
Indication: Empiric Type of Infection: URTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes